W e have recently celebrated the Centenary of G aspar V ianna and his great discovery o f the value of tartar emetic in the treatm ent of leishm aniasis.1 It is timely to mention the im portant work in C alcutta of D octor U pendranath Brahm achari. T he problems of toxicity of trivalent inorganic antimonials are well known and between the years of 1915-1921 Brahm achari carried out many experiments in a small laboratory attached to the Campbell M edicai School in C alcutta. H e first synthesised several new inorganic antimonials and achieved some treatm ent success with colloidal metallic antimony which was taken up by the reticulo endothelial system. Dissatisfied with these results however he tum ed his attention to organic aromatic antimonials inspired by the idea that an antimonial having a constitution similar to atoxyl (which was found by Ehrlich to be effective in sleeping sickness) might prove useful in kala azar. In 1919 supported by the Indian research fund he prepared PStibanilic A cid and various salts. In 1920 by heating Stibanilic A cid with urea he produced the first organic antimonial to achieve wide acceptance as a treatm ent for hum an leishmaniasis namely urea stibamine. The reason for this choice was that urea in combination with certain drugs reduces the pain on injection. Both Brahm achari and Shortt of the Indian M edicai Service found this drug to be extremely effective and safe in the treatm ent of kala azar. It saved thousands of lives in índia where it was manufactured on a commercial scale. However it proved difficult to standardise and has been superseded by the more satisfactory parental pentavalent antimonials2 which are still the first choice for the treatm ent of many forms of leishmaniasis today.
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Like G aspar Vianna, U pendranath Brahmachari also made many other important scientiftç dtscoveÚQS the reports of which are collected in two volumes under his authorship entitled Gleanings from my research3 4 published by the University of Calcutta in 1940 and 1941. F o r interested scholars these volumes are available for consultation in the Library of the Núcleo de Medicina Tropical e N utrição, Universidade de Brasília, under the accession numbers 1401 and 1402.1 am gratefiil to Dr. Leonard Goodwin for a generous gift of these volumes. 
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